Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2020-07-21 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
2020年第三次临时股东大会会议资料
Capital/Financing Update Classification · 95% confidence The document is titled as the "2020 Third Extraordinary General Meeting (EGM) Meeting Documents" of Liaoning Chengda Co., Ltd. It contains the agenda, proposals for approval regarding registration of medium-term notes and ultra-short-term financing bonds issuance limits, meeting time, voting methods, and authorization requests for the board chairman to decide issuance details. The content is focused on the meeting agenda and proposals for financing activities, not the actual issuance or financial results. The document is relatively short (2271 characters) and serves as meeting materials for a shareholder meeting rather than a full report or announcement of results. It is not a full Annual Report, Interim Report, or Earnings Release. It is not a voting result announcement or a proxy solicitation. The document is best classified as materials related to a shareholder meeting focused on capital/financing updates, specifically proposals for bond issuance registration and authorization. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-07-21 Chinese
关于分拆子公司上市的一般风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement related to the proposed spin-off and listing of a subsidiary company on the Shanghai Stock Exchange's Sci-Tech Innovation Board. It includes details about board meetings and shareholder meetings approving the spin-off plan, mentions regulatory approvals needed, and highlights investment risks. The document is short (910 characters) and serves as a public announcement of the transaction and associated risks rather than a detailed financial report or formal filing like a merger proxy or capital change notice. It does not contain financial statements or detailed financial data. The content fits best under a general regulatory announcement category related to corporate actions and risk disclosures. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-07-17 Chinese
招商证券股份有限公司关于辽宁成大股份有限公司分拆子公司辽宁成大生物股份有限公司至科创板上市之核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the spin-off and listing of a subsidiary (辽宁成大生物股份有限公司) on the Shanghai Stock Exchange's Science and Technology Innovation Board (科创板). It includes extensive financial data, compliance with regulatory requirements, legal and procedural confirmations, and assessments of the spin-off's impact on shareholders and creditors. The document is not a simple announcement but a comprehensive report with financial analysis and legal compliance verification related to a capital restructuring event (spin-off and listing). This fits the category of a Capital/Financing Update (CAP), as it concerns fundraising and capital structure changes through a subsidiary's listing. It is not an Annual Report, Audit Report, or Regulatory Filing, nor is it a simple announcement or presentation. The length and detail confirm it is a substantive report, not just an announcement.
2020-07-17 Chinese
分拆子公司辽宁成大生物股份有限公司至科创板上市预案（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed plan and proposal for the spin-off and listing of a subsidiary company (辽宁成大生物股份有限公司) on the Shanghai Stock Exchange's Science and Technology Innovation Board (科创板). It includes extensive information about the spin-off scheme, issuance plan, impact on the parent company, shareholder effects, risk factors, decision-making process, commitments, and regulatory approvals required. The document is titled as a "预案（修订案）" which translates to a "Plan (Revised)" for the spin-off listing. It is a comprehensive filing related to a capital restructuring and new share issuance for listing purposes. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, and capital structure changes. It is not an annual or interim report, nor a proxy or voting announcement, nor a regulatory filing or announcement of a report. The document length and content confirm it is a substantive filing, not just an announcement. Therefore, the correct classification is CAP with high confidence.
2020-07-17 Chinese
容诚会计师事务所关于辽宁成大前期会计差错更正的专项说明的审核报告
Audit Report / Information Classification · 95% confidence The document is an audit report specifically focused on the correction of prior period accounting errors for Liaoning Chengda Co., Ltd. It includes the auditor's responsibilities, management's responsibilities, and the auditor's conclusion on the special explanation of prior accounting error corrections. The document references auditing standards and regulatory disclosure rules related to financial information correction. It contains detailed financial adjustments for the years 2018 and 2019, showing the impact of the corrections on various financial statement items. The document is titled as an audit report and is not a full annual report or interim report but a standalone audit report on a specific accounting matter. Therefore, it fits the category of Audit Report / Information (AR). The document length is over 5,000 characters and contains substantive financial data and audit opinion, so it is not a mere announcement or certification. Hence, the classification is AR with high confidence.
2020-07-17 Chinese
容诚会计师事务所关于辽宁成大股份有限公司分拆子公司上市财务核查意见
Audit Report / Information Classification · 95% confidence The document is a financial verification opinion report issued by an accounting firm regarding the spin-off and listing of a subsidiary company (辽宁成大生物股份有限公司) on the Shanghai Stock Exchange's STAR Market. It references specific regulatory requirements from the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange rules concerning spin-offs of listed companies' subsidiaries. The document includes detailed financial data and compliance checks against the regulatory conditions for the spin-off listing. It is not a full annual or interim report but a specialized audit-related opinion focused on the spin-off transaction. The presence of an audit opinion and financial verification related to a capital market transaction indicates this is an Audit Report / Information (AR) rather than a full Annual Report or other category. The document length (6991 characters) and content confirm it is a standalone audit-related report rather than a brief announcement or a presentation. Therefore, the correct classification is AR with high confidence.
2020-07-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.